ATC code J05 Antivirals for systemic use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup J05 is part of the anatomical group J Antiinfectives for systemic use.
Contents
- J05AA Thiosemicarbazones
- J05AB Nucleosides and nucleotides excluding reverse transcriptase inhibitors
- J05AC Cyclic amines
- J05AD Phosphonic acid derivatives
- J05AE Protease inhibitors
- J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
- J05AG Non nucleoside reverse transcriptase inhibitors
- J05AH Neuraminidase inhibitors
- J05AR Antivirals for treatment of HIV infections combinations
- J05AX Other antivirals
- References
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QJ05.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
J05AA Thiosemicarbazones
J05AA01 MetisazoneJ05AB Nucleosides and nucleotides excluding reverse transcriptase inhibitors
J05AB01 AciclovirJ05AB02 IdoxuridineJ05AB03 VidarabineJ05AB04 RibavirinJ05AB06 GanciclovirJ05AB09 FamciclovirJ05AB11 ValaciclovirJ05AB12 CidofovirJ05AB13 PenciclovirJ05AB14 ValganciclovirJ05AB15 BrivudineJ05AB54 Ribavirin, combinationsJ05AC Cyclic amines
J05AC02 RimantadineJ05AC03 TromantadineJ05AD Phosphonic acid derivatives
J05AD01 FoscarnetJ05AD02 FosfonetJ05AE Protease inhibitors
J05AE01 SaquinavirJ05AE02 IndinavirJ05AE03 RitonavirJ05AE04 NelfinavirJ05AE05 AmprenavirJ05AE07 FosamprenavirJ05AE08 AtazanavirJ05AE09 TipranavirJ05AE10 DarunavirJ05AE11 TelaprevirJ05AE12 BoceprevirJ05AE13 FaldaprevirJ05AE14 SimeprevirJ05AE15 AsunaprevirJ05AF Nucleoside and nucleotide reverse transcriptase inhibitors
J05AF01 ZidovudineJ05AF02 DidanosineJ05AF03 ZalcitabineJ05AF04 StavudineJ05AF05 LamivudineJ05AF06 AbacavirJ05AF07 Tenofovir disoproxilJ05AF08 Adefovir dipivoxilJ05AF09 EmtricitabineJ05AF10 EntecavirJ05AF11 TelbivudineJ05AF12 ClevudineJ05AF13 Tenofovir alafenamideJ05AG Non-nucleoside reverse transcriptase inhibitors
J05AG01 NevirapineJ05AG02 DelavirdineJ05AG03 EfavirenzJ05AG04 EtravirineJ05AG05 RilpivirineJ05AH Neuraminidase inhibitors
J05AH01 ZanamivirJ05AH02 OseltamivirJ05AR Antivirals for treatment of HIV infections, combinations
J05AR01 Zidovudine and lamivudineJ05AR02 Lamivudine and abacavirJ05AR03 Tenofovir disoproxil and emtricitabineJ05AR04 Zidovudine, lamivudine and abacavirJ05AR05 Zidovudine, lamivudine and nevirapineJ05AR06 Emtricitabine, tenofovir disoproxil and efavirenzJ05AR07 Stavudine, lamivudine and nevirapineJ05AR08 Emtricitabine, tenofovir disoproxil and rilpivirineJ05AR09 Emtricitabine, tenofovir disoproxil, elvitegravir and cobicistatJ05AR10 Lopinavir and ritonavirJ05AR11 Lamivudine, tenofovir disoproxil and efavirenzJ05AR12 Lamivudine and tenofovir disoproxilJ05AR13 Lamivudine, abacavir and dolutegravirJ05AR14 Darunavir and cobicistatJ05AR15 Atazanavir and cobicistatJ05AR16 Lamivudine and raltegravirJ05AR17 Emtricitabine and tenofovir alafenamideJ05AR18 Emtricitabine, tenofovir alafenamide, elvitegravir and cobicistatJ05AR19 Emtricitabine, tenofovir alafenamide and rilpivirineJ05AX Other antivirals
J05AX01 MoroxydineJ05AX02 LysozymeJ05AX05 Inosine pranobexJ05AX06 PleconarilJ05AX07 EnfuvirtideJ05AX08 RaltegravirJ05AX09 MaravirocJ05AX10 MaribavirJ05AX11 ElvitegravirJ05AX12 DolutegravirJ05AX13 UmifenovirJ05AX14 DaclatasvirJ05AX15 SofosbuvirJ05AX16 DasabuvirJ05AX65 Sofosbuvir and ledipasvirJ05AX66 Dasabuvir, ombitasvir, paritaprevir and ritonavirJ05AX67 Ombitasvir, paritaprevir and ritonavirJ05AX68 Elbasvir and grazoprevirReferences
ATC code J05 Wikipedia(Text) CC BY-SA